OFFIPHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
OFFIPHARMA
Largest movements
- Stocks and contracts +€8,403
up €8,403 (+9.7%), from €86,858 to €95,261
- Receivables within one year +€6,001
up €6,001 (+5.6%), from €106,427 to €112,428
of which Trade receivables: +€9,943
- Tangible fixed assets -€4,581
down €4,581 (-52.0%), from €8,806 to €4,225
of which Furniture and vehicles: -€2,440
- Cash -€4,553
down €4,553 (-2.4%), from €188,824 to €184,271
mainly Stocks and contracts (-€8,403) and Receivables within one year (-€6,001)
- Trade debts +€18,899
up €18,899 (+19.8%), from €95,422 to €114,321
- Profit (loss) carried forward -€4,999
down €4,999 (-2.0%), from €245,666 to €240,667
- Other debts -€4,775
no longer reported in 2025 (was €4,775)
- Gross operating margin -€33,278
down €33,278 (-21.1%), from €157,990 to €124,712
- Taxes -€8,090
down €8,090 (-94.3%), from €8,578 to €488
- Depreciation -€3,401
down €3,401 (-42.6%), from €7,981 to €4,581
- Staff costs +€2,676
up €2,676 (+2.3%), from €115,734 to €118,410
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €393,514 | €399,757 | +€6,243 | +1.6% |
| Fixed assets | 21/28 | €8,806 | €4,225 | -€4,581 | -52.0% |
| Intangible fixed assets | 21 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €8,806 | €4,225 | -€4,581 | -52.0% |
| Furniture and vehicles | 24 | €2,440 | €0 | -€2,440 | -100% |
| Other tangible fixed assets | 26 | €6,365 | €4,225 | -€2,140 | -33.6% |
| Current assets | 29/58 | €384,708 | €395,532 | +€10,824 | +2.8% |
| Stocks and contracts in progress | 3 | €86,858 | €95,261 | +€8,403 | +9.7% |
| Stocks | 30/36 | €86,858 | €95,261 | +€8,403 | +9.7% |
| Amounts receivable within one year | 40/41 | €106,427 | €112,428 | +€6,001 | +5.6% |
| Trade receivables | 40 | €79,329 | €89,273 | +€9,943 | +12.5% |
| Other amounts receivable | 41 | €27,098 | €23,155 | -€3,943 | -14.5% |
| Cash at bank and in hand | 54/58 | €188,824 | €184,271 | -€4,553 | -2.4% |
| Deferred charges and accrued income | 490/1 | €2,599 | €3,572 | +€973 | +37.4% |
| Total equity and liabilities | 10/49 | €393,514 | €399,757 | +€6,243 | +1.6% |
| Equity | 10/15 | €266,126 | €261,127 | -€4,999 | -1.9% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €245,666 | €240,667 | -€4,999 | -2.0% |
| Amounts payable | 17/49 | €127,389 | €138,631 | +€11,242 | +8.8% |
| Amounts payable within one year | 42/48 | €127,389 | €138,631 | +€11,242 | +8.8% |
| Trade debts | 44 | €95,422 | €114,321 | +€18,899 | +19.8% |
| Suppliers | 440/4 | €95,422 | €114,321 | +€18,899 | +19.8% |
| Taxes, remuneration and social security | 45 | €27,192 | €24,310 | -€2,882 | -10.6% |
| Taxes | 450/3 | €2,976 | €3,168 | +€192 | +6.5% |
| Remuneration and social security | 454/9 | €24,216 | €21,142 | -€3,074 | -12.7% |
| Other amounts payable | 47/48 | €4,775 | - | -€4,775 | |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Remuneration, social security and pensions | 62 | €115,734 | €118,410 | +€2,676 | +2.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,981 | €4,581 | -€3,401 | -42.6% |
| Other operating charges | 640/8 | €1,079 | €1,280 | +€201 | +18.6% |
| Gross operating margin | 9900 | €157,990 | €124,712 | -€33,278 | -21.1% |
| Operating profit (loss) | 9901 | €33,196 | €442 | -€32,754 | -98.7% |
| Financial income | 75/76B | €33 | €41 | +€8 | +23.1% |
| Recurring financial income | 75 | €33 | €41 | +€8 | +23.1% |
| Financial charges | 65/66B | €5,459 | €4,994 | -€465 | -8.5% |
| Recurring financial charges | 65 | €5,459 | €4,994 | -€465 | -8.5% |
| Profit (loss) for the period before taxes | 9903 | €27,770 | -€4,512 | -€32,282 | |
| Income taxes | 67/77 | €8,578 | €488 | -€8,090 | -94.3% |
| Profit (loss) for the period | 9904 | €19,192 | -€4,999 | -€24,191 | |
| Profit (loss) for the period to be appropriated | 9905 | €19,192 | -€4,999 | -€24,191 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.